Can a targeted drug boost chemotherapy in advanced colorectal cancer?
Disease control
Completed
Researchers are testing whether adding fruquintinib to standard chemotherapy (mFOLFOX6 or FOLFIRI) helps people with metastatic colorectal cancer who have not yet received treatment for advanced disease. The trial enrolls adults up to age 75 with confirmed metastatic colorectal c…
Phase 2 • Sponsor: Zhou Fuxiang • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC